Clinical Trial Update: Efficacy of EMLA Cream Assisted Loco-sedation for Office-based Andrology Procedures [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating EMLA cream-assisted loco-sedation for office-based andrology procedures; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hydrocele
• Local Anesthesia
• Scrotal Hematoceles
• Scrotum Disease
• Spermatocele

Drugs mentioned

• EMLA Cream (lidocaine 2.5% / prilocaine 2.5% topical cream)

Snippet

Sponsor: University of Manitoba | Conditions: Scrotum Disease, Hydrocele Male | Phase 3 | Status: UNKNOWN